SE454403B - Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel - Google Patents

Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel

Info

Publication number
SE454403B
SE454403B SE8402938A SE8402938A SE454403B SE 454403 B SE454403 B SE 454403B SE 8402938 A SE8402938 A SE 8402938A SE 8402938 A SE8402938 A SE 8402938A SE 454403 B SE454403 B SE 454403B
Authority
SE
Sweden
Prior art keywords
fibronectin
protein
collagen
binding
cell surface
Prior art date
Application number
SE8402938A
Other languages
English (en)
Swedish (sv)
Other versions
SE8402938D0 (sv
SE8402938L (sv
Inventor
Magnus Hoeoek
Martin Kjell Lindberg
Torkel Mikael Wadstroem
Original Assignee
Alfa Laval Agri Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Laval Agri Int filed Critical Alfa Laval Agri Int
Priority to SE8402938A priority Critical patent/SE454403B/sv
Publication of SE8402938D0 publication Critical patent/SE8402938D0/xx
Priority to CA000482662A priority patent/CA1340401C/en
Priority to ES543635A priority patent/ES8900019A1/es
Priority to IE133785A priority patent/IE59203B1/en
Priority to NZ212244A priority patent/NZ212244A/xx
Priority to AT85850190T priority patent/ATE52543T1/de
Priority to JP60502661A priority patent/JPH0747541B2/ja
Priority to AU44331/85A priority patent/AU600886B2/en
Priority to PCT/SE1985/000227 priority patent/WO1985005553A1/en
Priority to DE8585850190T priority patent/DE3577579D1/de
Priority to EP85850190A priority patent/EP0163623B1/en
Publication of SE8402938L publication Critical patent/SE8402938L/
Priority to NO86860321A priority patent/NO164992C/no
Priority to FI860417A priority patent/FI84431C/fi
Publication of SE454403B publication Critical patent/SE454403B/sv
Priority to US07/801,593 priority patent/US5189015A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
SE8402938A 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel SE454403B (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel
CA000482662A CA1340401C (en) 1984-05-30 1985-05-29 Cell surface protein, process for its preparation, and the use of a cell surface protein thus obtained
ES543635A ES8900019A1 (es) 1984-05-30 1985-05-29 Un procedimiento para fabricar una proteina de la superficiede las celulas
IE133785A IE59203B1 (en) 1984-05-30 1985-05-29 The use of a cell surface protein obtained from staph.aureus
NZ212244A NZ212244A (en) 1984-05-30 1985-05-29 Preparation of cell surface protein of fibronectin binding properties useful as topical anti-infectant and vaccine
EP85850190A EP0163623B1 (en) 1984-05-30 1985-05-30 The use of a cell surface protein obtained from staph. aureus
JP60502661A JPH0747541B2 (ja) 1984-05-30 1985-05-30 細胞表面蛋白質とその製法及びその使用法
AT85850190T ATE52543T1 (de) 1984-05-30 1985-05-30 Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus.
AU44331/85A AU600886B2 (en) 1984-05-30 1985-05-30 Fibronectin-binding protein
PCT/SE1985/000227 WO1985005553A1 (en) 1984-05-30 1985-05-30 Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and profylactic treatment
DE8585850190T DE3577579D1 (de) 1984-05-30 1985-05-30 Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus.
NO86860321A NO164992C (no) 1984-05-30 1986-01-29 Fremgangsmaate for fremstilling av bakerielt overflateprotein med fibronektinbindende egenskaper.
FI860417A FI84431C (fi) 1984-05-30 1986-01-29 Foerfarande foer framstaellning av ett fibronektinbindande cellyteprotein.
US07/801,593 US5189015A (en) 1984-05-30 1991-12-05 Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel

Publications (3)

Publication Number Publication Date
SE8402938D0 SE8402938D0 (sv) 1984-05-30
SE8402938L SE8402938L (sv) 1985-12-01
SE454403B true SE454403B (sv) 1988-05-02

Family

ID=20356083

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel

Country Status (13)

Country Link
EP (1) EP0163623B1 (fi)
JP (1) JPH0747541B2 (fi)
AT (1) ATE52543T1 (fi)
AU (1) AU600886B2 (fi)
CA (1) CA1340401C (fi)
DE (1) DE3577579D1 (fi)
ES (1) ES8900019A1 (fi)
FI (1) FI84431C (fi)
IE (1) IE59203B1 (fi)
NO (1) NO164992C (fi)
NZ (1) NZ212244A (fi)
SE (1) SE454403B (fi)
WO (1) WO1985005553A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702272L (sv) * 1987-06-01 1988-12-02 Alfa Laval Agri Int Fibronektinbindande protein samt dess framstaellning
SE8801723D0 (sv) * 1988-05-06 1988-05-06 Staffan Normark Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
SE9003374D0 (sv) * 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
AU4837193A (en) * 1992-09-21 1994-04-12 Alfa-Laval Agri International Aktiebolag Fibrinogen binding protein
JPH0840932A (ja) * 1994-07-29 1996-02-13 Kitasato Inst:The スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
GB9415902D0 (en) * 1994-08-05 1994-09-28 Smithkline Beecham Plc Method of treatment
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
IL141639A (en) * 1998-08-31 2005-12-18 Inhibitex Inc Multicomponent vaccines
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
BRPI0408167B1 (pt) 2003-03-07 2014-10-21 Wyeth Corp Conjugados de polissacarídeo-proteína veículo adesina da superfície estafilocócica para imunização contra infecções nosocomiais
KR20080042865A (ko) * 2005-08-10 2008-05-15 아르네 포르스그렌 아베 모락셀라 카타랄리스와 상피세포, 세포외기질 단백질 및보체계의 상호작용
PE20110023A1 (es) 2009-06-22 2011-01-31 Wyeth Llc Composiciones inmunogenicas de antigenos de staphylococcus aureus
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
TW201302779A (zh) 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide

Also Published As

Publication number Publication date
EP0163623A3 (en) 1987-02-25
ATE52543T1 (de) 1990-05-15
FI84431B (fi) 1991-08-30
DE3577579D1 (de) 1990-06-13
IE851337L (en) 1985-11-30
NO860321L (no) 1986-01-29
ES8900019A1 (es) 1988-11-01
SE8402938D0 (sv) 1984-05-30
WO1985005553A1 (en) 1985-12-19
EP0163623B1 (en) 1990-05-09
FI860417A0 (fi) 1986-01-29
FI860417A (fi) 1986-01-29
JPS61502334A (ja) 1986-10-16
FI84431C (fi) 1991-12-10
EP0163623A2 (en) 1985-12-04
IE59203B1 (en) 1994-01-26
NO164992C (no) 1990-12-05
NO164992B (no) 1990-08-27
CA1340401C (en) 1999-02-23
ES543635A0 (es) 1988-11-01
SE8402938L (sv) 1985-12-01
JPH0747541B2 (ja) 1995-05-24
AU600886B2 (en) 1990-08-30
NZ212244A (en) 1989-03-29

Similar Documents

Publication Publication Date Title
US5189015A (en) Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
SE454403B (sv) Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel
US5980908A (en) Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
JP3430853B2 (ja) 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
AU4433185A (en) Fibronectin-binding protein
US20160068590A9 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
EP1926811B1 (en) Protein a production and purification without using animal derived components
Loganathan et al. Lysozyme, protease, alkaline phosphatase and esterase activity of epidermal skin mucus of freshwater snake head fish Channa striatus
SE446688B (sv) Medel for avlegsnande av mikroorganismer fran vevnader, vilket bestar av ett protein som kan bindas till mikroorganismerna
Cole et al. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. II. Cellular requirements for T cell transformation mediated by a soluble Mycoplasma mitogen.
US6391315B1 (en) Vaccine for inhibiting and preventing induced staphylococcus infection, isolated antigens used therein, and isolated antibodies induced thereby
CA2257826A1 (en) Helicobacter pylori adhesin binding group antigen
US5703040A (en) Broad spectrum antibiotic peptide
Barta et al. Inhibition of lymphocyte blastogenesis by whey
Schauer et al. Sialidase activity in the sera of patients and rabbits with clostridial myonecrosis
US6884412B1 (en) Dectection of and methods and composition for prevention and/or treatment of papillomatous digital dermatitis
US20020107174A1 (en) Composition comprising endotoxin neutralizing protein and derivatives and uses thereof
Kessel et al. Endotoxin cytotoxicity: role of cell-associated antibody.
Hartsell The newer knowledge of lysozyme and bacteria
AU714222B2 (en) Helicobacter pylori antigen
Mamo et al. Adhesion of Staphylococcus aureus to bovine mammary epithelial cells induced by growth in milk whey
Hibbitt et al. The antimicrobial activity of cationic proteins isolated from the cells in bulk milk samples
Whelihan The isolation and characterization of antibacterial factors from bovine seminal plasma and pancreas: a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Microbiology at Massey University
Bharadwaj et al. Umbilical cord blood serum extract as an antimicrobial biomaterial on streptococcus mutans and Lactobacillus acidophilus
JPH07274993A (ja) 抗原の調製方法及び抗体

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8402938-8

Format of ref document f/p: F

NUG Patent has lapsed